 | • レポートコード：MRC2305C142 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、227ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、世界の敗血症診断市場規模が2021年に462.38百万ドル、2022年に507.14百万ドルとなり、更に年平均9.86％成長して2027年には812.92百万ドルに達すると予測しています。当市場調査レポートでは、敗血症診断の世界市場を総合的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、検査種類別分析（臨床検査、POC検査）、技術別分析（フローサイトメトリー、免疫学的検査、微生物、分子診断）、製品別分析（アッセイキット＆試薬、血液培養培地、器具、ソフトウェア）、方法別分析（自動診断、従来型診断）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの内容を掲載しています。なお、当書には、Abbott Laboratories、Alifax S.r.l.、Beckman Coulter, Inc.、Becton, Dickinson and Company、bioMérieux SA、Boditech Med Inc.、Bruker Corporation、Cerner Corporation、CytoSorbents Corporation、EKF Diagnostics、Epic Systems Corporationなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の敗血症診断市場規模：検査種類別 - 臨床検査の市場規模 - POC検査の市場規模 ・世界の敗血症診断市場規模：技術別 - フローサイトメトリーの市場規模 - 免疫学的検査の市場規模 - 微生物の市場規模 - 分子診断の市場規模 ・世界の敗血症診断市場規模：製品別 - アッセイキット＆試薬の市場規模 - 血液培養培地の市場規模 - 器具の市場規模 - ソフトウェアの市場規模 ・世界の敗血症診断市場規模：方法別 - 自動診断の市場規模 - 従来型診断の市場規模 ・世界の敗血症診断市場規模：地域別 - 南北アメリカの敗血症診断市場規模 アメリカの敗血症診断市場規模 カナダの敗血症診断市場規模 ブラジルの敗血症診断市場規模 ... - アジア太平洋の敗血症診断市場規模 日本の敗血症診断市場規模 中国の敗血症診断市場規模 インドの敗血症診断市場規模 韓国の敗血症診断市場規模 台湾の敗血症診断市場規模 ... - ヨーロッパ/中東/アフリカの敗血症診断市場規模 イギリスの敗血症診断市場規模 ドイツの敗血症診断市場規模 フランスの敗血症診断市場規模 ロシアの敗血症診断市場規模 ... - その他地域の敗血症診断市場規模 ・競争状況 ・企業情報 |
The Global Sepsis Diagnostic Market size was estimated at USD 462.38 million in 2021 and expected to reach USD 507.14 million in 2022, and is projected to grow at a CAGR 9.86% to reach USD 812.92 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Sepsis Diagnostic to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Testing Type, the market was studied across Laboratory Testing and PoC Testing.
Based on Technology, the market was studied across Flow Cytometry, Immunoassays, Microbiology, and Molecular Diagnostics.
Based on Product, the market was studied across Assay Kits and Reagents, Blood Culture Media, Instruments, and Software.
Based on Method, the market was studied across Automated Diagnostics and Conventional Diagnostics.
Based on Pathogen, the market was studied across Bacterial Sepsis and Fungal Sepsis. The Bacterial Sepsis is further studied across Gram-Negative Bacteria and Gram-Positive Bacteria.
Based on End-user, the market was studied across Hospitals, Pathology & Reference Laboratories, and Research Laboratories & Academic Institutes.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Sepsis Diagnostic market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Sepsis Diagnostic Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Sepsis Diagnostic Market, including Abbott Laboratories, Alifax S.r.l., Beckman Coulter, Inc., Becton, Dickinson and Company, bioMérieux SA, Boditech Med Inc., Bruker Corporation, Cerner Corporation, CytoSorbents Corporation, EKF Diagnostics, Epic Systems Corporation, F. Hoffmann-La Roche AG, GenMark Diagnostics, Immunexpress Inc., Koninklijke Philips N.V., Luminex Corporation, McKesson Corporation, Response Biomedical Corporation, Seegene Inc., Thermo Fisher Scientific, Inc., and Wolters Kluwer N.V..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Sepsis Diagnostic Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Sepsis Diagnostic Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Sepsis Diagnostic Market?
4. What is the competitive strategic window for opportunities in the Global Sepsis Diagnostic Market?
5. What are the technology trends and regulatory frameworks in the Global Sepsis Diagnostic Market?
6. What is the market share of the leading vendors in the Global Sepsis Diagnostic Market?
7. What modes and strategic moves are considered suitable for entering the Global Sepsis Diagnostic Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Incidence and Prevalence of Sepsis
5.1.1.2. Growing Occurrence of Hospital Derived Infections
5.1.1.3. Development of Technology Advanced Diagnostic Solutions
5.1.2. Restraints
5.1.2.1. Capital Intensive Automated Diagnostic Services and Dearth of Reimbursement Situations
5.1.3. Opportunities
5.1.3.1. Emerging Development of Rapid Diagnostics Globally
5.1.3.2. Development of Novel Biomarkers for Sepsis Diagnostics
5.1.4. Challenges
5.1.4.1. Lack of Awareness and Standard Protocols for the Procedure
5.2. Cumulative Impact of COVID-19
6. Sepsis Diagnostic Market, by Testing Type
6.1. Introduction
6.2. Laboratory Testing
6.3. PoC Testing
7. Sepsis Diagnostic Market, by Technology
7.1. Introduction
7.2. Flow Cytometry
7.3. Immunoassays
7.4. Microbiology
7.5. Molecular Diagnostics
8. Sepsis Diagnostic Market, by Product
8.1. Introduction
8.2. Assay Kits and Reagents
8.3. Blood Culture Media
8.4. Instruments
8.5. Software
9. Sepsis Diagnostic Market, by Method
9.1. Introduction
9.2. Automated Diagnostics
9.3. Conventional Diagnostics
10. Sepsis Diagnostic Market, by Pathogen
10.1. Introduction
10.2. Bacterial Sepsis
10.3.1. Gram-Negative Bacteria
10.3.2. Gram-Positive Bacteria
10.3. Fungal Sepsis
11. Sepsis Diagnostic Market, by End-user
11.1. Introduction
11.2. Hospitals
11.3. Pathology & Reference Laboratories
11.4. Research Laboratories & Academic Institutes
12. Americas Sepsis Diagnostic Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Sepsis Diagnostic Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Sepsis Diagnostic Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis, By Key Player
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. Abbott Laboratories
16.1.1. Business Overview
16.1.2. Key Executives
16.1.3. Product & Services
16.2. Alifax S.r.l.
16.2.1. Business Overview
16.2.2. Key Executives
16.2.3. Product & Services
16.3. Beckman Coulter, Inc.
16.3.1. Business Overview
16.3.2. Key Executives
16.3.3. Product & Services
16.4. Becton, Dickinson and Company
16.4.1. Business Overview
16.4.2. Key Executives
16.4.3. Product & Services
16.5. bioMérieux SA
16.5.1. Business Overview
16.5.2. Key Executives
16.5.3. Product & Services
16.6. Boditech Med Inc.
16.6.1. Business Overview
16.6.2. Key Executives
16.6.3. Product & Services
16.7. Bruker Corporation
16.7.1. Business Overview
16.7.2. Key Executives
16.7.3. Product & Services
16.8. Cerner Corporation
16.8.1. Business Overview
16.8.2. Key Executives
16.8.3. Product & Services
16.9. CytoSorbents Corporation
16.9.1. Business Overview
16.9.2. Key Executives
16.9.3. Product & Services
16.10. EKF Diagnostics
16.10.1. Business Overview
16.10.2. Key Executives
16.10.3. Product & Services
16.11. Epic Systems Corporation
16.11.1. Business Overview
16.11.2. Key Executives
16.11.3. Product & Services
16.12. F. Hoffmann-La Roche AG
16.12.1. Business Overview
16.12.2. Key Executives
16.12.3. Product & Services
16.13. GenMark Diagnostics
16.13.1. Business Overview
16.13.2. Key Executives
16.13.3. Product & Services
16.14. Immunexpress Inc.
16.14.1. Business Overview
16.14.2. Key Executives
16.14.3. Product & Services
16.15. Koninklijke Philips N.V.
16.15.1. Business Overview
16.15.2. Key Executives
16.15.3. Product & Services
16.16. Luminex Corporation
16.16.1. Business Overview
16.16.2. Key Executives
16.16.3. Product & Services
16.17. McKesson Corporation
16.17.1. Business Overview
16.17.2. Key Executives
16.17.3. Product & Services
16.18. Response Biomedical Corporation
16.18.1. Business Overview
16.18.2. Key Executives
16.18.3. Product & Services
16.19. Seegene Inc.
16.19.1. Business Overview
16.19.2. Key Executives
16.19.3. Product & Services
16.20. Thermo Fisher Scientific, Inc.
16.20.1. Business Overview
16.20.2. Key Executives
16.20.3. Product & Services
16.21. Wolters Kluwer N.V.
16.21.1. Business Overview
16.21.2. Key Executives
16.21.3. Product & Services
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing